World News | Third US Vaccine Could Raise Question: Which Shots Are Best?
Get latest articles and stories on World at LatestLY. The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson and Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?
Washington, Feb 26 (AP) The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson and Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?
If cleared for emergency use, the J and J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.
“I think it's going to be huge,” said Dr. Virginia Caine, director of the public health department in Marion County, Indiana, which includes Indianapolis.
She expects the easier-to-use vaccine will give local officials more flexibility for mobile vaccination clinics or pop-up events.
The challenge will be explaining how protective the J and J shot is after the astounding success of the first U.S. vaccines.
Two doses of the Pfizer and Moderna shots were found to be about 95 per cent effective against symptomatic COVID-19.
The numbers from J and J's study are not that high, but they are not an apples-to-apples comparison. One dose of the J and J vaccine was 85 per cent protective against the most severe COVID-19. After adding in moderate cases, the total effectiveness dropped to about 66 per cent.
“I don't think it's a second-tier vaccine, but we've got to avoid that perception,” said Dr. Thomas Balcezak of Yale New Haven Health System.
The J and J shot was tested in the U.S., Latin America and South Africa at a time when more contagious mutated versions of the virus were spreading.
That wasn't the case last fall, when Pfizer and Moderna were wrapping up testing, and it's not clear if their numbers would hold against the most worrisome of those variants.
Importantly, the Food and Drug Administration reported this week that, just like its predecessors, the J and J shot offers strong protection against the worst outcomes.
By 28 days after the injection, there were no hospitalisations or deaths in study volunteers given the J and J shot, compared with 16 hospitalisations and seven deaths in those given a dummy shot.
Independent advisers to the FDA will recommend Friday if there's enough evidence to allow widespread use of J and J's vaccine, setting the stage for a final decision within days.
If it rolls out next week, U.S. officials expect to have only a few million doses to divide between states in initial shipments.
But by the end of March, J and J has said it can supply enough to vaccinate 20 million people — a much-needed boost to stretched supplies.
The bottom line: “Whatever vaccine is being offered is what you want,” said University of Pennsylvania immunologist E. John Wherry.
Still, the nuances of the vaccines raise ethical questions.
At Yale, Balcezak is struggling with how to make the best use of the J and J shot's advantages without appearing to target it to underserved populations.
For example, it's a logical choice for homeless shelters where people may have moved on before their second dose of the Pfizer or Moderna vaccine.
“I'm very worried about how that would be perceived,” Balcezak said.
The J and J vaccine is also easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen.
Balcezak said the Yale system has been working with pastors and other “cultural ambassadors” to answer vaccine questions from minority communities, and likewise will discuss the J and J shot's possibilities.
In Washington state, health officials see some clear need for one-and-done vaccinations — including sailors in the maritime industry, who can spend months on cargo and fishing vessels.
“This is the ideal vaccine for them,” said Dr. Scott Lindquist of the Washington State Department of Health.
With the two-dose vaccines, the state “had to send second doses onward to the next port of call.”
Other parts of the world already are facing which-is-best challenges.
AstraZeneca's vaccine, for instance, is cleared for use in Britain and Europe after data suggested it was about 70 per cent effective.
Italy's government recently decided to reserve Pfizer and Moderna shots for the elderly and designate the AstraZeneca vaccine for younger, at-risk workers, sparking protest from the country's main teachers' union.
In the U.S., health officials say it's critical for the government to send a clear message.
“Right now, it's not vaccine against vaccine, it's vaccine against virus,” said Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention. (AP)
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)
Indian Institute of Management Mumbai, Starburst Partner To Boost Aerospace, New Space and Defence Start-Ups in India
Good Friday 2024: PM Narendra Modi Recalls Profound Sacrifice of Jesus Christ on Good Friday, Says ‘It Teaches People Compassion and Forgiveness’
Patna Shuklla Review: Critics Hail Raveena Tandon's Performance in This 'Decent' Courtroom Drama
Jammu and Kashmir Road Accident: 10 Killed As Cab Plunges Into Deep Gorge on Jammu-Srinagar National Highway in Ramban (Watch Videos)
Sex Trafficking Racket Busted in Delhi: Lured With Job Offer, Woman Held as Captive in Vasant Kunj Flat and ‘Offered’ to Clients; Rescued by Police
‘Friends, Captains and Most Importantly…’, Virat Kohli and Shane Watson Share a Laugh During RCB Training Session Ahead of IPL 2024 Match Against KKR (View Post)
Read More
PM Narendra Modi Security Vehicles: National Green Tribunal Denies 5-Year Extension for Registration of Armoured Vehicles Used by SPG for Prime Minister’s Security
Ecuador Shocker: Guayaquil Prison Becomes Battleground As Prisoners Clash With Military
London Shocker: Teenager Allegedly Stabs Man on Moving Train Near Beckenham, Arrested on Suspicion of Attempted Murder After Disturbing Video Goes Viral
‘No Sane Man Would Believe It’: Watchman Accused of Having Forcible Sex With Woman at Crowded Juhu Chowpatty Gets Bail, Bombay HC Terms Complainant’s Version ‘Unbelievable’
‘Lions Do Not Run They Walk Slowly’: Gujarat High Court Rejects Railways’ Claim That Asiatic Lions Death From Train Hits Took Place While Chasing Prey
Robbery Caught on Camera in Telangana: Miscreant Smashes Car Window, Makes Away With Rs Two Lakh Cash in Jangaon
- INR
- USD
- EUR
-
Bitcoin(BTC)₹58,78,8201.17%
-
Ethereum(ETH)₹2,98,1061.76%
-
Tether(USDT)₹83.410.11%
-
BNB(BNB)₹50,3432.82%
City | Petrol | Diesel |
---|---|---|
New Delhi | 96.72 | 89.62 |
Kolkata | 106.03 | 92.76 |
Mumbai | 106.31 | 94.27 |
Chennai | 102.74 | 94.33 |
- INR
- USD
- EUR
-
Bitcoin(BTC)₹58,78,8201.17%
-
Ethereum(ETH)₹2,98,1061.76%
-
Tether(USDT)₹83.410.11%
-
BNB(BNB)₹50,3432.82%
City | Petrol | Diesel |
---|---|---|
New Delhi | 96.72 | 89.62 |
Kolkata | 106.03 | 92.76 |
Mumbai | 106.31 | 94.27 |
Chennai | 102.74 | 94.33 |
Currency | Price | Change |
---|
-
Bengaluru Horror: Man Collapses, Dies at Hospital After Friend Inserts Nozzle of Powerful Blow-Dryer Into His Rectum in Sampigehalli; Accused Arrested
-
Bhiwandi Shocker: Class 10 Student Allegedly Assaulted, Stabbed With Knife by Three Students for Not Helping in Copying During SSC Exam; Trio Booked
-
Bengaluru Shocker: 18-Year-Old Assaulted With Cricket Bat After Objecting to Body Shaming in T Dasarahalli, Three Arrested
-
Mumbai: 14-Year-Old Girl Dies by Suicide After Painful Experience During Her First Menstrual Period